Yangjing Lv
Lishui, 323000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
3-Hydroxyquinolin-2-Ones Act as Dual Inhibitors of Ferroptosis and Monoamine Oxidase B: Reducing Alzheimer's Disease-Related Amyloid Precursor Protein and Hyperphosphorylated Tau In Vivo.
Journal: Journal of medicinal chemistry
Published: June 21, 2025
Discovery of novel benzimidazole derivatives as selective and reversible monoamine oxidase B inhibitors for Parkinson's disease treatment.
Journal: European journal of medicinal chemistry
Published: March 04, 2024
Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer's disease.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: November 13, 2023
Monoamine oxidase B inhibitors based on natural privileged scaffolds: A review of systematically structural modification.
Journal: International journal of biological macromolecules
Published: June 06, 2023
Exploration of the novel phthalimide-hydroxypyridinone derivatives as multifunctional drug candidates against Alzheimer's disease.
Journal: Bioorganic chemistry
Published: May 30, 2023
Chromone-based monoamine oxidase B inhibitor with potential iron-chelating activity for the treatment of Alzheimer's disease.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: December 15, 2022
Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer's disease.
Journal: Bioorganic chemistry
Published: December 14, 2020
Rational design, synthesis and biological evaluation of novel multitargeting anti-AD iron chelators with potent MAO-B inhibitory and antioxidant activity.
Journal: Bioorganic & medicinal chemistry
Published: January 02, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026